These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29119617)

  • 1. Computer-aided design of human sialyltransferase inhibitors of hST8Sia III.
    Dobie C; Montgomery AP; Szabo R; Skropeta D; Yu H
    J Mol Recognit; 2018 Feb; 31(2):. PubMed ID: 29119617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational characterisation of the interactions between human ST6Gal I and transition-state analogue inhibitors: insights for inhibitor design.
    Montgomery A; Szabo R; Skropeta D; Yu H
    J Mol Recognit; 2016 May; 29(5):210-22. PubMed ID: 26669681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of α-Hydroxy-1,2,3-Triazole-linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2.
    Szabo R; Dobie C; Montgomery AP; Steele H; Yu H; Skropeta D
    ChemMedChem; 2024 Aug; 19(16):e202400088. PubMed ID: 38758134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I.
    Montgomery AP; Dobie C; Szabo R; Hallam L; Ranson M; Yu H; Skropeta D
    Bioorg Med Chem; 2020 Jul; 28(14):115561. PubMed ID: 32616185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities.
    Szabo R; Skropeta D
    Med Res Rev; 2017 Mar; 37(2):219-270. PubMed ID: 27678392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation.
    Montgomery AP; Skropeta D; Yu H
    Sci Rep; 2017 Oct; 7(1):14428. PubMed ID: 29089525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.
    Dobie C; Montgomery AP; Szabo R; Yu H; Skropeta D
    RSC Med Chem; 2021 Oct; 12(10):1680-1689. PubMed ID: 34778769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological evaluation of sulfonate and sulfate analogues of lithocholic acid: A bioisosterism-guided approach towards the discovery of potential sialyltransferase inhibitors for antimetastatic study.
    Perez SJLP; Chen CL; Chang TT; Li WS
    Bioorg Med Chem Lett; 2024 Jun; 105():129760. PubMed ID: 38641151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intrinsic Relationship Between Structure and Function of the Sialyltransferase ST8Sia Family Members.
    Huang RB; Cheng D; Liao SM; Lu B; Wang QY; Xie NZ; Troy Ii FA; Zhou GP
    Curr Top Med Chem; 2017; 17(21):2359-2369. PubMed ID: 28413949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review.
    Al Saoud R; Hamrouni A; Idris A; Mousa WK; Abu Izneid T
    Biomed Pharmacother; 2023 Sep; 165():115091. PubMed ID: 37421784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialyltransferase inhibition and recent advances.
    Wang L; Liu Y; Wu L; Sun XL
    Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
    Izumi M; Wada K; Yuasa H; Hashimoto H
    J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives.
    Perez SJLP; Fu CW; Li WS
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of B- and C-ring-modified lithocholic acid analogues as potential sialyltransferase inhibitors.
    Abdu-Allah HH; Chang TT; Li WS
    Steroids; 2016 Aug; 112():54-61. PubMed ID: 27154753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational and electrostatic analysis of S
    Crous W; Naidoo KJ
    Bioorg Med Chem; 2016 Oct; 24(20):4998-5005. PubMed ID: 27614914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialyltransferase inhibitors: consideration of molecular shape and charge/hydrophobic interactions.
    Kumar R; Nasi R; Bhasin M; Huan Khieu N; Hsieh M; Gilbert M; Jarrell H; Zou W; Jennings HJ
    Carbohydr Res; 2013 Aug; 378():45-55. PubMed ID: 23374752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soyasaponin I, a potent and specific sialyltransferase inhibitor.
    Wu CY; Hsu CC; Chen ST; Tsai YC
    Biochem Biophys Res Commun; 2001 Jun; 284(2):466-9. PubMed ID: 11394903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.
    Skropeta D; Schwörer R; Haag T; Schmidt RR
    Glycoconj J; 2004; 21(5):205-19. PubMed ID: 15486453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis for Binding of Fluorescent CMP-Neu5Ac Mimetics to Enzymes of the Human ST8Sia Family.
    Volkers G; Lizak C; Niesser J; Rosell FI; Preidl J; Gnanapragassam VS; Horstkorte R; Rademann J; Strynadka NCJ
    ACS Chem Biol; 2018 Aug; 13(8):2320-2328. PubMed ID: 30015474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
    Li W; Niu Y; Xiong DC; Cao X; Ye XS
    J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.